Exome Asset Management LLC Centessa Pharmaceuticals PLC Transaction History
Exome Asset Management LLC
- $133 Billion
- Q4 2024
A detailed history of Exome Asset Management LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Exome Asset Management LLC holds 137,716 shares of CNTA stock, worth $2.07 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
137,716
Previous 138,152
0.32%
Holding current value
$2.07 Million
Previous $2.21 Billion
4.42%
% of portfolio
1.73%
Previous 1.49%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$301 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$150 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$146 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$95.6 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$87.4 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.42B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...